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Background: The beta-3 adrenergic receptor (β3-AR) Trp64Arg and uncoupling protein 1 (UCP1) -3826 A > G
polymorphisms have been reported to be associated with obesity and/or lipid metabolism in some populations.
This study examined the possible association of the β3-AR and UCP1 polymorphisms with overweight/obesity or
lipid variation in a Southwest Chinese population.
Methods: A total of 418 Han Chinese (249 overweight/obese and 169 healthy control subjects) in the Chengdu
area were studied using PCR-RFLP analysis. Total serum cholesterol (TC) and triglycerides (TGs) were measured using
an enzymatic method. High density lipoprotein cholesterol (HDL-C) was determined after sodium phosphotungstate/
magnesium chloride precipitation of low-density lipoproteins by polyvinyl sulfate. Serum apolipoproteins were
quantified by radial immunodiffusion.
Results: The genotype and allele frequencies of the β3-AR Trp64Arg and UCP1 -3826 A > G polymorphisms in
overweight/obese subjects exhibited no significant differences compared to the controls. However, subjects
carrying the β3-AR TrpTrp genotype and UCP1 AG genotype had higher TG levels than those carrying the Arg
allele and AA genotype, respectively (P < 0.05), while controls carrying the β3-AR Arg allele had significantly higher
TC and apo AII concentrations than those carrying the TrpTrp genotype (P < 0.05). Additionally, subjects carrying
the UCP1 AG genotype exhibited elevated apo C-II and apo C-III levels compared to those carrying the AA genotype
(P < 0.05). We were unable to find an association of the UCP1 and β3-AR polymorphisms with low HDL-cholesterolemia
in the overweight/obese subjects.
Conclusions: The present study provides evidence that the β3-AR Trp64Arg and UCP1 -3826 A > G polymorphisms
are associated with TG levels in overweight/obese Chinese subjects and that the two polymorphisms are also associated
with certain lipid and apolipoprotein variations, depending on BMI. However, these polymorphisms are not associated
with overweight/obesity or low HDL-cholesterolemia in a Chinese population from the Chengdu area.
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Table 1 Clinical and biochemical characteristics of the
overweight/obese and control subjects (x  s)
Overweight/obese
(n = 249)
Controls (n = 169) P
Age (yrs) 55.04 ± 10.00 53.35 ± 11.78 0.115
Gender (M/F) 149/100 93/76 0.322
TG (mmol/L) 2.31 ± 1.70 1.72 ± 1.56 0.000
TC (mmol/L) 5.43 ± 0.92 5.41 ± 1.11 0.788
HDL-C (mmol/L) 1.17 ± 0.32 1.41 ± 0.41 0.000
LDL-C (mmol/L) a3.29 ± 0.87 b3.26 ± 1.04 0.821
apoA-I (mg/dL) 124.20 ± 27.96 128.97 ± 23.89 0.077
apoA-II (mg/dL) 28.39 ± 4.58 29.07 ± 6.92 0.227
apoB100 (mg/dL) 88.93 ± 17.06 84.04 ± 20.93 0.427
apoC-II (mg/dL) 6.68 ± 3.32 5.61 ± 3.10 0.001
apoC-III (mg/dL) 17.47 ± 7.03 13.09 ± 6.17 0.000
Apo E (mg/dL) 5.27 ± 1.96 4.87 ± 2.26 0.043
BMI (kg/m2) 25.72 ± 2.25 20.74 ± 1.60 0.000
Subjects with TG > 4.516 mmol/L (400 mg/dL) were excluded when calculating
the serum LDL-C levels, a: n = 193, b: n = 145.
Table 2 Genotype and allele frequencies of the β3-AR
Thr64Arg and UCP1 -3826 A > G polymorphisms in the







β3-AR Trp64Arg Genotype 0.414
Trp Trp 0.739 (184) 0.734 (124)
Trp Arg 0.253 (63) 0.243 (41)
Arg Arg 0.008 (2) 0.024 (4)
Allele 0.668
Trp 0.865 (431) 0.855 (289)
Arg 0.135 (67) 0.145 (49)
UCP1 -3826 A/G Genotype 0.824
AA 0.249 (62) 0.225 (38)
AG 0.454 (113) 0.479 (81)
GG 0.297 (74) 0.296 (50)
Allele 0.746
A 0.476 (237) 0.464 (157)
G 0.524 (261) 0.536 (181)
Numbers in parentheses indicate the number of subjects with each genotype
or number of alleles of each type.
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Obesity is strongly associated with an adverse dyslipidemic
profile and increased risks for diabetes, hypertension, and
coronary artery disease. Although this relationship has
been described in detail, its pathophysiological basis re-
mains unclear.
Studies have suggested that obesity is linked to genetic
and environmental factors and that most obesity-
predisposing genes encode the molecular components of
the physiological systems regulating energy balance [1].
The β3-AR gene has been established as the principal
mediator of thermogenesis in brown adipose tissue and lip-
olysis in white adipose tissue both in animals and humans
[2-4]. A β3-AR Trp64Arg polymorphism decreases recep-
tor sensitivity [5,6] and may be associated with obesity and
related traits [5,7,8]. The human uncoupling protein-1,
which is expressed in brown adipose tissue, dissipates the
transmitochondrial proton gradient as heat and plays an
important role in energy homeostasis and thermogenesis
[9,10]. UCP1 gene polymorphisms have been implicated in
the pathogenesis of obesity and related metabolic disor-
ders, including lipid disorders [11,12]. A −3826 A >G poly-
morphism within the promoter region of the UCP-1 gene
is a candidate gene polymorphic site related to these disor-
ders [13-15]. Additionally, several studies have also sug-
gested that the UCP1 -3826 A >G and β3-AR Trp64Arg
polymorphisms are related to low HDL-cholesterolemia
and HDL-cholesterol levels in some populations [16-20].
However, the results of these studies were not confirmed
in other studies [21-26]. Furthermore, no data concerning
the relationships between the β3-AR Trp64Arg and UCP1
-3826A >G polymorphisms and overweight/obesity and
lipid profiles have been reported for a Southwest Chinese
population. Therefore, we undertook this population-
based study to assess whether the β3-AR Trp64Arg and
UCP1 -3826 A >G polymorphisms were related to over-
weight/obesity and lipid profiles in a Southwest Chinese
population.
Results
Baseline characteristics of the participants in the
population
The lipid and lipoprotein profiles for both the over-
weight/obese and control groups are provided in Table 1.
The serum TG, apo CII, apo C-III and apoE levels were
significantly higher and the HDL-C was significantly lower
in the overweight/obese group compared to the control
group (P < 0.05 or P < 0.01).
Allele frequencies
The PCR amplified fragments (containing the β 3-AR
Trp64Arg and UCP1 -3826 A >G polymorphic sites) from
each sample were digested with the restriction enzyme Bst
NI for the Trp64Arg site and Bcl I for the −3826 A >Gsite; then, the digested fragments were analysed by agarose
gel electrophoresis.
Genotypes of the Trp64Arg and −3826 A > G polymor-
phisms were found to be in Hardy-Weinberg equilib-
rium in both the overweight/obese and control groups.
The frequency data are presented in Table 2.
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at codon 64 in the overweight/obese and normal control
groups were 0.865, 0.135 and 0.855, 0.145, respectively,
while the A and G allele frequencies at the −3826 A >G
site of the UCP1 gene were 0.476, 0.524 and 0.464, 0.536,
respectively. The allele frequencies of the two polymor-
phisms in the overweight/obese subjects were not differ-
ent from those in the controls (P > 0.05).
Moreover, no significant difference in genotype fre-
quencies was observed when the genotypes were divided
into two categories according to the dominant model or
recessive model at the β3-AR Trp64Arg and UCP1 -3826
A >G sites (all P > 0.05). Multiple logistic regression
analysis was used to assess the association of the β3-AR
Trp64Arg and UCP1 -3826 A >G polymorphisms with
overweight/obesity. Assuming a dominant or recessive in-
heritance model, no association of the two polymorphisms
were found after adjusting for age and sex (all P > 0.05).Effects of polymorphic sites of the β3-AR and UCP1 genes
on serum concentrations of lipids and apolipoproteins
To assess the possible impact of the polymorphic sites in
the β3-AR and UCP1 genes on lipid metabolism, we ana-
lysed serum lipid and lipoprotein levels in subjects posses-
sing the different genotypes of the Trp64Arg and −3826
A >G polymorphisms in both the overweight/obese and
normal control groups.
In the overweight/obese group, subjects with the TrpTrp
genotype at the Trp64Arg site of the β3-AR gene had
higher serum TG concentrations than the Arg allele car-
riers (TG: 2.40 ± 1.79 mmol/L vs 1.95 ± 1.11 mmol/L, P <
0.05) (Table 3), while in the normal controls the Arg allele
carriers had higher TC and apoA-II concentrations than
the TrpTrp genotype carriers (all P < 0.05) (Table 3).Table 3 Mean values x  sð Þ of serum lipid and apolipoprotei
overweight/obese and control groupsΔ
Overweight/obese
TrpTrp (n = 184) Trp Arg + ArgArg (
TG (mmol/L) 2.40 ± 1.79 1.95 ± 1.11a,*
TC (mmol/L) 5.58 ± 1.02 5.33 ± 0.77
HDL-C (mmol/L) 1.16 ± 0.31 1.24 ± 0.36
LDL-C (mmol/L) d3.32 ± 0.91 e3.19 ± 0.73
apoA-I (mg/dL) 125.21 ± 29.49 124.33 ± 21.42
apoA-II (mg/dL) 28.54 ± 4.75 28.48 ± 4.90
apoB100 (mg/dL) 93.44 ± 20.74 86.50 ± 14.41
apoC-II (mg/dL) 6.88 ± 3.50 6.12 ± 2.64
apoC-III (mg/dL) 15.92 ± 7.53 14.21 ± 4.79
Apo E (mg/dL) 5.39 ± 2.11 4.95 ± 1.42
abcCompared with genotype TrpTrp carriers in the same group, respectively, *P < 0.0
Subjects with TG > 4.516 mmol/L (400 mg/dL) were excluded when calculating the
ΔAge and sex were used as covariates in the analysis to adjust for the genotype effIn the overweight/obese group, subjects with the AG
genotype of the A >G polymorphism of the UCP1 gene
had a higher serum mean concentration of TG, apo C-II
and apo C-III compared to patients with the AA genotype
(Table 4; all P < 0.05). No significant effect on lipid and apo-
lipoprotein levels was observed for the UCP1 -3826 A >G
polymorphism in the normal control subjects.Evaluation of the relationship between polymorphic sites
in the β3-AR and UCP1 genes and low HDL-cholesterolemia
Previous studies have suggested that the UCP1 -3826 A >
G polymorphism was related to low HDL-cholesterolemia
and low HDL-cholesterol levels in some populations with
obesity. Additionally, the β3-AR Trp64Arg polymorphism
has been shown to be related to low HDL-cholesterol
levels in some ethnic groups. Therefore, we analysed the
relationship between polymorphic sites in the β3-AR and
UCP1 genes and low cholesterolemia in our population.
In the overweight/obese subjects, the allele frequencies
of the two polymorphisms in subjects with HDL-C <
1.04 mmol/L were not different from those with HDL-
C ≥ 1.04 mmol/L (Table 5, both P > 0.05).Discussion
Our results in the Chinese cohort living in Southwest
China showed that both the polymorphisms in the β3-AR
and UCP1 genes were associated with TG concentrations
in overweight/obese subjects and that the two polymor-
phisms were also associated with some lipid and apolipo-
protein levels (i.e., TC, apoAII, apo CII and apo CIII
levels) depending on BMI. However, we did not find an
association between the polymorphisms and overweight/
obesity or low HDL-cholesterolemia in overweight/obese
subjects. These results provide support for the notion thatn levels for the Thr64 Arg site of the β3-AR gene in the
Controls
n = 65) TrpTrp (n = 124) TrpArg + ArgArg (n = 45)
1.64 ± 1.05 2.05 ± 1.54
5.36 ± 1.04 5.77 ± 1.42b,*
1.41 ± 0.41 1.44 ± 0.42
f3.21 ± 1.01 g3.42 ± 1.15
130.21 ± 22.58 126.13 ± 27.23
28.53 ± 4.21 31.26 ± 11.61c,*
89.38 ± 21.27 83.70 ± 23.98
5.52 ± 2.95 5.99 ± 3.69
13.04 ± 5.69 13.76 ± 7.67
4.75 ± 1.78 5.35 ± 3.29
5.
serum LDL-C levels, d: n = 142, e: n = 51, f: n = 108, g: n = 37.
ects.
Table 4 Mean values (x  s) of serum lipid and apolipoprotein levels for the −3826 A > G site of the UCP1 gene in the
overweight/obese and control groupsΔ
Overweight/Obese Controls
AA (n = 62) AG (n = 119) GG (n = 74) AA (n = 38) AG (n = 83) GG (n = 53)
TG (mmol/L) 1.92 ± 1.21 2.53 ± 1.94a,* 2.23 ± 1.50 1.58 ± 0.83 1.64 ± 1.19 1.88 ± 2.25
TC (mmol/L) 5.28 ± 1.00 5.43 ± 0.86 5.58 ± 0.90 5.39 ± 1.17 5.41 ± 1.03 5.38 ± 1.19
HDL-C (mmol/L) 1.20 ± 0.29 1.17 ± 0.33 1.17 ± 0.31 1.44 ± 0.51 1.43 ± 2.34 1.38 ± 0.41
LDL-C (mmol/L) d3.16 ± 0.97 e3.24 ± 0.81 f3.44 ± 0.87 g3.20 ± 1.21 h3.21 ± 1.01 i3.19 ± 0.98
apoA-I (mg/dL) 126.06 ± 21.68 125.33 ± 34.42 120.59 ± 18.45 125.77 ± 25.14 130.36 ± 23.34 128.83 ± 24.14
apoA-II (mg/dL) 28.89 ± 4.49 28.38 ± 4.79 27.98 ± 4.35 28.52 ± 4.62 28.87 ± 8.82 29.71 ± 4.12
apoB100 (mg/dL) 100.15 ± 113.51 88.99 ± 17.13 91.14 ± 16.67 88.08 ± 25.74 91.23 ± 88.77 81.35 ± 19.56
ApoC-II (mg/dL) 5.81 ± 2.63 7.22 ± 3.66b,* 6.58 ± 2.91 5.31 ± 2.91 5.61 ± 2.81 5.73 ± 3.59
ApoC-III (mg/dL) 13.99 ± 6.75 16.30 ± 7.25c,* 15.24 ± 6.29 12.53 ± 5.23 13.04 ± 5.60 13.22 ± 7.52
Apo E (mg/dL) 4.93 ± 1.77 5.47 ± 2.07 5.18 ± 1.80 4.55 ± 1.54 4.89 ± 1.89 4.95 ± 3.08
abcCompared with AA genotype carriers in the same group, respectively, *p < 0.05;
Subjects with TG > 4.516 mmol/L (400 mg/dL) were excluded when calculating the serum LDL-C levels, d: n = 43, e: n = 90, f: n = 60, g: n = 34, h: n = 71, i: n = 40.
ΔAge and sex were used as covariates in the analysis to adjust for the genotype effects.
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metabolic disorders.
A total of 423 SNPs in β3-AR and 460 SNPs in UCP1
in both the coding and non-coding regions are available
in the public database. Although to date the function of
a substantial number of the SNPs in the genes has not
been defined, those linked to protein coding substitutionsTable 5 Genotype and allele frequencies of the β3-AR
Trp64Arg and UCP1 -3826 A >G polymorphisms according







β3-AR Trp64Arg Genotype 0.893a
Trp Trp 0.762 (77) 0.743 (110)
Trp Arg 0.228 (23) 0.250 (37)
Arg Arg 0.010 (1) 0.007 (1)
Allele 0.794
Trp 1.752 (177) 1.736 (257)
Arg 0.248 (25) 0.264 (39)
UCP1 -3826 A > G Genotype 0.243b
AA 0.198 (20) 0.291 (43)
AG 0.485 (49) 0.446 (66)
GG 0.317 (32) 0.264 (39)
Allele 0.110
A 0.881 (89) 1.027 (152)
G 1.119 (113) 0.973 (144)
Numbers in parentheses indicate the number of subjects with each genotype
or number of alleles of each type.
aArgArg + TrpArg vs. TrpTrp, χ2 = 1.118, odds radio (ArgArg + TrpArg/TrpTrp) =
0.902, 95% confidence interval 0.501-1.625.
bGG vs. AA + AG, χ2 = 0.837, odds radio (GG/AA + AG) =1.296, 95% confidence
interval 0.743-2.261.and in the introns, 5’ and 3’ UTRs related to the regulation
of gene expression are of potential functional relevance.
Among these SNPs, the most widely studied are the β3-
AR Trp64Arg and UCP1 -3826 A >G due to their func-
tional importance.
There have been many studies concerning the relation-
ship between the Trp64Arg polymorphism of the β3-AR
gene and obesity or related phenotypes; however, the re-
sults are inconsistent. Clement et al. [5] reported that
Arg64 resulted in an increased tendency to accumulate
weight in French subjects and that this polymorphism
was also associated with obesity [8], difficulty in weight
loss and a lower basal metabolic rate [27] in Japanese
subjects. In contrast, Ghosh et al. [28] reported that the
β3-AR polymorphism was not associated with obesity in
a large Finnish sample population, and Shiwaku et al. also
did not find an association with moderately overweight
Japanese workers [29]. Our results are in line with the re-
ports of Ghosh et al. and Shiwaku et al. The discrepancy
among these studies may be caused by several factors, in-
cluding environmental and genetic factors.
With respect to the effect of the β3-AR Trp64Arg poly-
morphism on lipids and apolipoproteins, Kim-Motoyama
et al. [20] reported that the polymorphism was associated
with obesity and decreased serum TG levels. Our results
in overweight/obese Chinese are in line with the report. A
previous report suggested that subjects with this mutation
may be characterized by decreased lipolysis in visceral adi-
pose tissues [20]. In the current study, we also found that
the Arg allele carriers showed increased TC and apo AII
concentrations compared to Trp allele carriers in the
normal control subjects, which is in general consistent
with the notion that the β3-AR polymorphism is associ-
ated with cholesterol metabolism, including a variation of
HDL-C components such as apoA-II. We were unable to
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and HDL-C levels in our population, although reports
have suggested that the Arg64 allele carriers of the β3-
AR gene had decreased HDL-C levels in some popula-
tions [19,20].
There are several reports available concerning the ef-
fect of the UCP1 -3826A > G polymorphism on obesity
or plasma metabolic parameters. However, controversy
remains because some reports do not support this role.
For instance, Urhammer et al. [30] showed that the
UCP1 polymorphism was not associated with obesity in
a Danish population, and Pihlajamaki et al. [31] reported
that BMI and serum biochemistry were not significantly
different based on UCP1 genotype in Finnish subjects
with family combined hyperlipidemia. Schaffler et al. [26]
showed that the G allele of UCP1 was not associated with
obesity and metabolic parameters in a large sample of
German subjects. The current study is supportive of the re-
sults from the Danish, Finnish and German populations.
Interestingly, we found that TG, apoC-II and apoC-III
levels in overweight/obese subjects were elevated in AG
genotype carriers compared with AA genotype carriers,
suggesting a link between impaired metabolic levels in
overweight/obese subjects and this polymorphism.
Kotani et al. reported that the UCP1 -3826A > G poly-
morphism was associated with low HDL-cholesterolemia
in obese Japanese patients [32]. In the current study we
are unable to find a similar effect in overweight/obese
subjects (OR = 1.296, CI = 0.743-2.261, P = 0.360), suggest-
ing that UCP1 gene variation might not predispose over-
weight/obese Chinese subjects to the development of low
HDL-cholesterolemia. Our result is in line with the re-
ports in German Caucasians [26] and young Japanese
males [33]. Interestingly, we found that other gene poly-
morphisms, such as ABCA1 R219K, were associated with
low HDL-cholesterolemia in our overweight/obese sub-
jects (n = 206, OR = 2.243, CI = 1.232-4.083, P = 0.008)
(data not shown), suggesting that genetic variant(s)
other than UCP1 might predispose Chinese populations
to low HDL-cholesterolemia.
Although the patient and control subjects participating
in this study were randomized at enrollment into the re-
spective overweight/obese and control groups, both groups
had similar socioeconomic statuses (i.e., salary and educa-
tion) and background environmental factors (i.e., diet and
place of residence), and we attempted to control for some
potential confounding factors such as age and sex in the
data analyses, there might still have been some degree of
uncontrolled confounding factors (i.e., smoking and forms
of exercise). Future studies that examine whether any of
these confounding factors additionally acted as effect mod-
ifiers on the relationship between the genotype and disease
or related phenotypes will provide a more complete picture
of genetic variations and the linked disease.Finally, we should note that the difference in findings
might reflect true variability in the association among
different populations or ethnic groups. The above reports
suggest that the role of the β3-AR and UCP-1 polymor-
phisms is complex. Obesity and related metabolic disorders
may be determined by multiple factors, such as environ-
mental and life style components, in addition to genetic
components in which many candidates genes and their in-
teractions may be involved.
Conclusions
The present study provides evidence that the β3-AR
Trp64Arg and UCP1 -3826 A >G polymorphisms are as-
sociated with TG levels in overweight/obese Chinese sub-
jects and that the two polymorphisms are also associated
with certain lipid and apolipoprotein variations, depending
on BMI. However, these polymorphisms are not associ-
ated with overweight/obesity or low HDL-cholesterolemia
in a Chinese population from the Chengdu area.
Methods
Subjects
For this study, blood samples were collected from 418 vol-
unteers (242 men, 176 women, aged 53.77 ± 11.29 years)
who were taking part in a routine health examination at
the three hospitals of Sichuan University and Sichuan
Normal University in Chengdu, China. All of these subjects
were current or retired staff members of the Universities
and were apparently healthy and unrelated individuals.
After a 12 to 14 hour overnight fast, the blood from each
individual was collected and analysed for serum concentra-
tions of lipids, lipoproteins and apolipoproteins. BMI was
calculated from height and weight measurements using the
formula: BMI = body weight/(height)2 in kg/m2. According
to the World Health Organization guidelines for Asians,
individuals with BMI ≥ 23 kg/m2 are classified as over-
weight and those with BMI ≥ 25 kg/m2 are classified as
obese [34]. Low HDL-cholesterolemia was defined as
HDL-C < 1.04 mmol/L [35]. For the case–control study,
249 overweight/obese subjects (149 men, 100 women,
aged 55.04 ± 10.00 years) with a BMI ≥23 kg/m2 and 169
normal weight (BMI < 23) subjects (93 men, 76 women,
aged 53.35 ± 11.78 years) were used as the patients and
controls, respectively. All of the subjects were Han Chinese
living in the Chengdu area. Subjects with internal implica-
tions, such as CHD, diabetes mellitus and hypertension,
were excluded. All study participants provided their in-
formed consent, and the study was approved by the institu-
tional review board of the hospitals of Sichuan University
and Sichuan Normal University.
Quantitative analysis
Total serum cholesterol (TC) and triglycerides (TGs)
were measured by enzymatic methods (kits, Zhong Sen
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(HDL-C) was determined after sodium phosphotung-
state/magnesium chloride precipitation of low-density
lipoprotein by polyvinyl sulfate. Serum apo A-I, apoA-II,
apo B100, apo C-II, apo C-III and apo E were quantified
using a radial immunodiffusion kit developed by our la-
boratory [36]. The serum LDL-C concentration was calcu-
lated according to the Friedewald equation [37].
DNA extraction and genotyping
Genomic DNA was isolated from 500 μl of peripheral
blood according to the method of Erlich [38]. The PCRs
were performed in a final volume of 25 μl containing
10% 10× PCR buffer, 2 mM MgCl2, 0.2 mM dNTPs, 0.5 U
Taq DNA polymerase (MBI Fermentas) and 0.5 μM of
each sense and antisense primer. We used 100 ng of DNA
per PCR reaction. Genotypes for polymorphic β3-AR the
Trp64Arg and UCP1 -3826 A >G polymorphisms were
determined as previously described [7,18].
Statistical analysis
Comparisons of continuous variables between two or
more groups were performed with an independent t-test
or one-way ANOVA, respectively. Allele frequencies of
the beta3-AR and UCP1 gene polymorphisms were esti-
mated by the gene counting method. Allele and genotype
frequencies were compared between cases and controls by
a chi-square test. Genotypes were also assessed according
to the dominant and recessive genetic model. Each genetic
model comprised two groups: the combined group of vari-
ant homozygotes and heterozygotes vs wild-type homozy-
gotes for the dominant model; and variant homozygotes vs
the combined group of wild-type homozygotes and hetero-
zygotes for the recessive model. Multiple logistic regression
analysis with a stepwise forward selection procedure was
performed to calculate odds ratios (OR) with obesity as a
dependent variable and genotype according to the above
genetic models in the presence of confounders (age and
sex) as independent variables. Differences were considered
statistically significant at a p-value <0.05. The statistical
analyses were performed using the Statistical Package for
Social Sciences (SPSS 11.0 for Windows).
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